Peripherally Inserted Central Catheters Market Trends
Advancements in peripherally inserted central catheters (PICCs) have been driven by the need for safer, more reliable, and patient-friendly intravenous access.
For instance, the development of antimicrobial catheter materials and coatings, which help reduce the risk of bloodstream infections associated with long-term catheter use. These antimicrobial properties inhibit bacterial growth on the catheter surface, lowering the incidence of catheter-related bloodstream infections (CRBSIs) and improving patient outcomes.
Additionally, the integration of imaging technologies such as ultrasound and fluoroscopy into PICC insertion procedures, which allows healthcare providers to accurately place the catheter tip in the central venous system, minimizing the risk of malposition and complications.
Moreover, advancements in catheter design, such as the use of radiopaque materials and tip-locating devices, facilitate precise catheter tip visualization during insertion and subsequent monitoring, further enhancing patient safety.
Furthermore, the incorporation of innovative features such as valved catheter hubs and anti-reflux devices helps prevent blood reflux and occlusion, prolonging catheter patency and reducing the need for catheter replacements. These advancements contribute to the overall growth and adoption of PICCs in clinical practice worldwide.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Peripherally inserted central catheters (PICC) industry size was worth USD 1.3 billion in 2023 and is projected to expand at 9.6% CAGR from 2024 to 2032, due to the increasing prevalence of infectious diseases and rising incidence of chronic conditions worldwide.
The power injected segment in the Peripherally inserted central catheters (PICC) market accumulated USD 599.2 million in revenue in 2023, owing to their ability to withstand higher injection pressures and their suitability for delivering contrast media or medications at rapid infusion rates.
North America peripherally inserted central catheters (PICC) industry size was USD 447 million in 2023 and is projected to expand at significant rate between 2024 and 2032, on account of the well-developed healthcare infrastructure with advanced hospitals, clinics, and ambulatory surgical centers.
Access Vascular, Inc., AngioDynamic, Inc., Argon Medical, B. Braun Medical Ltd, Becton, Dickinson and Company, Biowy Corporation, Cardinal Health, Inc., Footprint Medical Incorporated, ICU Medical, Inc., Kimal Plc, Medi-Tech Devices, and Teleflex Incorporated
Peripherally Inserted Central Catheters Market Scope